DCGI nod to Hetero Labs’ Favipiravir for treating mild-to-moderate Covid-19

DCGI nod to Hetero Labs’ Favipiravir for treating mild-to-moderate Covid-19

New Delhi, Sep 25 (PTI) Drug firm Hetero on Friday said it has launched a pack of its generic oral antiviral drug– Favivir 800/200– for the treatment of mild-to-moderate symptomatic COVID-19 patien…
Read More

Leave a Reply